Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Haplotypes | 11 | 2019 | 2759 | 1.000 |
Why?
|
Major Histocompatibility Complex | 7 | 2017 | 913 | 0.920 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2019 | 3398 | 0.230 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2896 | 0.230 |
Why?
|
Chromosomes, Human, Pair 6 | 4 | 2014 | 376 | 0.220 |
Why?
|
Tetanus Toxoid | 2 | 2001 | 193 | 0.220 |
Why?
|
Hepatitis B Surface Antigens | 2 | 2001 | 301 | 0.210 |
Why?
|
Pedigree | 4 | 2019 | 4565 | 0.200 |
Why?
|
Gene Frequency | 9 | 2019 | 3588 | 0.200 |
Why?
|
Liposomes | 5 | 1997 | 774 | 0.190 |
Why?
|
HLA-DQ Antigens | 2 | 2014 | 208 | 0.190 |
Why?
|
HLA Antigens | 3 | 2019 | 1355 | 0.180 |
Why?
|
Membrane Lipids | 2 | 1993 | 251 | 0.180 |
Why?
|
Multifactorial Inheritance | 2 | 2006 | 1339 | 0.170 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5787 | 0.170 |
Why?
|
Linkage Disequilibrium | 4 | 2014 | 1990 | 0.150 |
Why?
|
HLA-C Antigens | 3 | 2010 | 147 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 7 | 2018 | 17684 | 0.120 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 191 | 0.110 |
Why?
|
Penetrance | 2 | 2006 | 388 | 0.110 |
Why?
|
Erythrocyte Membrane | 3 | 1993 | 439 | 0.110 |
Why?
|
Membrane Fusion | 3 | 1991 | 265 | 0.110 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2019 | 15669 | 0.100 |
Why?
|
Alleles | 6 | 2017 | 6886 | 0.100 |
Why?
|
Receptors, KIR | 2 | 2010 | 113 | 0.100 |
Why?
|
Genes, Dominant | 1 | 2014 | 864 | 0.100 |
Why?
|
Immunoglobulin Allotypes | 1 | 2010 | 55 | 0.090 |
Why?
|
Conserved Sequence | 1 | 2014 | 1165 | 0.090 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2007 | 1330 | 0.090 |
Why?
|
Chromosome Mapping | 3 | 2007 | 4627 | 0.090 |
Why?
|
Molecular Chaperones | 1 | 2014 | 743 | 0.090 |
Why?
|
Recombination, Genetic | 1 | 2014 | 1527 | 0.090 |
Why?
|
Models, Genetic | 2 | 2018 | 3439 | 0.080 |
Why?
|
Simian immunodeficiency virus | 2 | 1991 | 805 | 0.080 |
Why?
|
Genotype | 4 | 2018 | 12876 | 0.080 |
Why?
|
HLA-A Antigens | 2 | 2006 | 226 | 0.070 |
Why?
|
HLA-DR4 Antigen | 1 | 2006 | 29 | 0.070 |
Why?
|
HLA-DR3 Antigen | 1 | 2006 | 33 | 0.070 |
Why?
|
Genes, MHC Class I | 1 | 2007 | 239 | 0.070 |
Why?
|
Cytokines | 2 | 2003 | 7261 | 0.070 |
Why?
|
Immunoglobulins | 2 | 2006 | 864 | 0.070 |
Why?
|
Cardiolipins | 4 | 1993 | 81 | 0.060 |
Why?
|
Base Sequence | 2 | 2014 | 12439 | 0.060 |
Why?
|
Complement C2 | 1 | 2003 | 70 | 0.060 |
Why?
|
Dysgammaglobulinemia | 1 | 2003 | 21 | 0.060 |
Why?
|
Hepacivirus | 1 | 2010 | 1333 | 0.050 |
Why?
|
HIV-1 | 4 | 1993 | 6826 | 0.050 |
Why?
|
HLA-B Antigens | 1 | 2004 | 330 | 0.050 |
Why?
|
Lymphocyte Subsets | 1 | 2002 | 310 | 0.050 |
Why?
|
Complementarity Determining Regions | 1 | 2001 | 148 | 0.040 |
Why?
|
Hepatitis C | 1 | 2010 | 1580 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12482 | 0.040 |
Why?
|
Genetic Variation | 2 | 2007 | 6506 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2003 | 4279 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 3 | 1993 | 2513 | 0.040 |
Why?
|
Calcium | 2 | 1991 | 5704 | 0.040 |
Why?
|
Twins, Dizygotic | 1 | 2018 | 236 | 0.040 |
Why?
|
Stochastic Processes | 1 | 2018 | 352 | 0.040 |
Why?
|
Heterozygote | 4 | 2006 | 2787 | 0.040 |
Why?
|
Twins, Monozygotic | 1 | 2018 | 465 | 0.030 |
Why?
|
Interleukin-4 | 1 | 2000 | 1113 | 0.030 |
Why?
|
Humans | 24 | 2019 | 756111 | 0.030 |
Why?
|
Immunoglobulin D | 2 | 2006 | 57 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2002 | 1427 | 0.030 |
Why?
|
Polymerase Chain Reaction | 4 | 2010 | 6067 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2000 | 1163 | 0.030 |
Why?
|
Homozygote | 3 | 2004 | 1783 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1997 | 1250 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2000 | 1872 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2003 | 5418 | 0.030 |
Why?
|
Cations, Divalent | 1 | 1993 | 167 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4569 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2018 | 979 | 0.030 |
Why?
|
Genome, Human | 1 | 2006 | 4391 | 0.030 |
Why?
|
DNA | 2 | 2004 | 7222 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2002 | 2181 | 0.030 |
Why?
|
Phosphatidylcholines | 2 | 1990 | 406 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2003 | 2716 | 0.020 |
Why?
|
Insulin | 1 | 2006 | 6571 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2001 | 2521 | 0.020 |
Why?
|
Fluorescence | 1 | 1993 | 749 | 0.020 |
Why?
|
Hungary | 1 | 2010 | 82 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29764 | 0.020 |
Why?
|
Gangliosides | 1 | 1990 | 132 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 1993 | 2560 | 0.020 |
Why?
|
Viral Envelope Proteins | 1 | 1993 | 636 | 0.020 |
Why?
|
Phosphatidylserines | 1 | 1990 | 188 | 0.020 |
Why?
|
Kinetics | 2 | 1993 | 6371 | 0.020 |
Why?
|
Vaccination | 1 | 2000 | 3339 | 0.020 |
Why?
|
Centromere | 1 | 2007 | 213 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 12203 | 0.020 |
Why?
|
Minisatellite Repeats | 1 | 2006 | 162 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 1997 | 2211 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1219 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 21259 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3717 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2000 | 12755 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1997 | 4421 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1990 | 3087 | 0.020 |
Why?
|
Jews | 1 | 2006 | 359 | 0.010 |
Why?
|
Cell Line | 3 | 2007 | 15638 | 0.010 |
Why?
|
IgG Deficiency | 1 | 2003 | 29 | 0.010 |
Why?
|
Complement Factor B | 1 | 2003 | 72 | 0.010 |
Why?
|
IgA Deficiency | 1 | 2003 | 43 | 0.010 |
Why?
|
Cell Membrane | 1 | 1993 | 3675 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2006 | 971 | 0.010 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2003 | 488 | 0.010 |
Why?
|
Virus Replication | 1 | 1990 | 2424 | 0.010 |
Why?
|
Receptors, KIR2DL1 | 1 | 2002 | 15 | 0.010 |
Why?
|
Receptors, KIR2DL3 | 1 | 2002 | 17 | 0.010 |
Why?
|
Receptors, KIR3DL1 | 1 | 2002 | 27 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2003 | 787 | 0.010 |
Why?
|
Complement System Proteins | 1 | 2004 | 781 | 0.010 |
Why?
|
CHO Cells | 1 | 2003 | 1388 | 0.010 |
Why?
|
Quaternary Ammonium Compounds | 2 | 1991 | 203 | 0.010 |
Why?
|
Cricetinae | 1 | 2003 | 2422 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3785 | 0.010 |
Why?
|
Family | 1 | 2010 | 3188 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2003 | 1415 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2003 | 1608 | 0.010 |
Why?
|
Endocytosis | 1 | 2003 | 964 | 0.010 |
Why?
|
Receptors, IgG | 1 | 2002 | 569 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2003 | 1865 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2001 | 1991 | 0.010 |
Why?
|
Adult | 4 | 2010 | 218302 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9259 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2004 | 1824 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10491 | 0.010 |
Why?
|
Epitopes | 1 | 2003 | 2502 | 0.010 |
Why?
|
Animals | 3 | 2004 | 167069 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1776 | 0.010 |
Why?
|
Cell Communication | 1 | 2003 | 1634 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4171 | 0.010 |
Why?
|
E-Selectin | 1 | 1997 | 575 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5781 | 0.010 |
Why?
|
United States | 2 | 2018 | 71909 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 1997 | 6533 | 0.010 |
Why?
|
Phenotype | 2 | 2004 | 16442 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2006 | 4526 | 0.010 |
Why?
|
Age Factors | 1 | 2010 | 18372 | 0.010 |
Why?
|
Aged | 2 | 2010 | 167585 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 4448 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4284 | 0.010 |
Why?
|
Body Mass Index | 1 | 2010 | 12844 | 0.010 |
Why?
|
Drug Carriers | 1 | 1997 | 702 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4703 | 0.010 |
Why?
|
Middle Aged | 2 | 2010 | 218357 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2003 | 4342 | 0.010 |
Why?
|
Parainfluenza Virus 1, Human | 1 | 1991 | 25 | 0.010 |
Why?
|
Cardiovascular System | 1 | 1997 | 849 | 0.010 |
Why?
|
Orthomyxoviridae | 1 | 1991 | 148 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1991 | 1636 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 17607 | 0.000 |
Why?
|
Male | 3 | 2010 | 356852 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2001 | 9113 | 0.000 |
Why?
|
DNA, Viral | 1 | 1990 | 2184 | 0.000 |
Why?
|
Female | 3 | 2010 | 388229 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2001 | 20002 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1997 | 18929 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1997 | 15659 | 0.000 |
Why?
|
Concepts
(160)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_